Gene Query: AHSA1

Dataset Description Geneva Score
EP400 is required for Max and MCPyV mediated gene activation 88.68
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 88.58
4sU-seq of HFF exposed to salt and heat stress 57.89
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 36.5
Genome wide expression change by RNF168 knocking down in NEC cells 36.37
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 36.29
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 36.29
RNA sequencing of GlyH-101-treated MCF-7 cell line 36.13
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 34.12
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 28.36
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 28.15
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 27.51
Genome wide miR-191 target profile determined by RIP and gene expression profiling 27.51
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 27.06
RIG-I and MDA5 fRIP during KSHV lytic reactivation 26.32
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 25.87
Differential expression of genes in AD169-infected MRC5. 25.37
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 25.13
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 24.39
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 23.3
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 23.08
Endothelial gene expression analysis 21.4
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 21.4
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 21.3
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 20.61
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 20.45
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 20.45
FOXD3 is a novel tumor suppressor in lung cancer 20.16
Gene expression changes after LOC550643 silencing 19.79
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 19.2
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 18.99
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 18.62
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 18.44
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 18.35
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 18.17
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 18.17
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 18.02
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 17.75
Gene expression profiling of leukemia cells following asparagine depletion 17.45
RNA-seq in transgenic cells 17.02
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 16.79
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 16.79
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 16.68
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 16.68
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 16.25
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 16.18
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 16.12
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 16.0
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 15.79
The role of FAM46C in myeloma cells 15.62
The role of FAM46C in myeloma cells [sequencing] 15.62
MeRIP-seq for heat shock in B-cell lymphoma cells 15.3
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 15.15
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 15.15
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 14.96
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 14.94
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.46
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 14.33
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 14.27
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 14.27
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 14.25
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 14.24
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 14.24
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 14.17
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 14.12
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 14.12
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 14.07
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 14.07
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 13.9
3’ Uridylation Expands miRNA Target Repertoire 13.73
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 13.53
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 13.53
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 13.36
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 13.29
RNA-seq of resting and activated CD4+ T cells +-JQ1 13.23
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 13.22
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 13.18
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 13.13
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 13.08
MicroRNA targetome analysis during HCMV infection 13.0
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 12.91
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 12.79
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 12.79
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 12.74
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 12.53
Exogenous rescue of KLHL9 in SF210 cell line 12.5
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 12.38
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 12.33
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 12.33
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 12.24
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 12.24
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 12.2
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 12.19
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.12
Effect of FGF13 depletion on the H460 cell line 12.1
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 11.98
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 11.96
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 11.86
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.82
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.63
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 11.54
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 11.52
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 11.52
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.52
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 11.49
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 11.37
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 11.27
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 11.27
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 11.26
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 11.23
A role for ZNF598 in post-transcriptional gene regulation 11.22
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 11.15
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.14
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 11.06
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 11.01
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 11.01
Effect of disulfiram treatment on pediatric high grade glioma 10.96
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.94
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 10.83
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 10.83
LncRNA-GAS5 negative regulation of YAP-target genes expression 10.81
Transcriptome analysis upon C6orf203 silencing 10.78
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 10.77
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 10.76
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 10.76
RNA sequencing of BT142 and TS603 cell lines 10.76
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 10.76
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 10.74
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.68
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 10.59
RNA sequencing of primary human platelets and in vitro cell lines 10.59
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.55
CD73 knockdown effect in pancreatic cancer cell lines 10.54
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 10.49
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 10.47
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 10.43
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 10.43
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 10.36
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 10.29
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 10.27
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 10.17
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 10.09
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 10.09
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 10.08
NRDE2 negatively regulates nuclear exosome functions 10.08
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 10.07
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 10.07
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 9.96
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 9.94
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 9.94
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 9.93
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 9.9
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 9.89
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 9.89
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 9.8
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 9.76
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.74
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 9.73
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.68
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.68
Identification of Sin3B regulated genes during quiescence 9.64
MYCi361 regulates MYC target genes 9.62
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.6
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 9.57
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 9.53
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 9.53
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 9.49
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 9.49
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 9.48
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 9.48
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 9.46
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.46
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 9.44
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 9.43
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 9.42
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 9.4
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 9.4
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 9.39
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 9.36
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 9.36
High-throughput sequencing of pluripotent cells 9.3
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 9.3
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.24
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 9.23
scRNASeq analysis of cycling cardiomyocytes 9.22
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 9.2
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 9.18
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 9.18
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 9.15
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.12
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 9.11
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 9.06
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 9.04
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 9.03
Expression and functions of long noncoding RNAs during human T helper cell differentiation 8.98
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.97
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.97
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 8.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 8.94
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 8.94
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 8.88
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.83
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.81
Regulating Interleukin-2 activity with engineered receptor signaling clamps 8.78
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 8.76
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 8.64
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 8.63
HNF1 regulates critical functions of the human epididymis epithelium. 8.63
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 8.63
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 8.62
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 8.59
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.54
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.54
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.53
STRIPAK directs PP2A activity to promote oncogenic transformation 8.5
The human blood-nerve barrier transcriptome 8.47
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.47
Developmental stage specific chromosome architecture in human erythroid cells 8.45
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.45
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.42
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 8.38
MYC dependent mRNA translation shapes gene expression and cell biology 8.38
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 8.35
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.33
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 8.27
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.27
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 8.26
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.23
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 8.2
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 8.2
miR941 overexpression experiment 8.15
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 8.07
Mitochondrial dsRNA triggers antiviral signalling in humans 8.02
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 8.0
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 7.95
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 7.94
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.92
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.9
Ebola virus (EBOV) infection of ARPE-19 cells 7.88
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 7.85
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.84
Lipid degradation promotes prostate cancer cell survival 7.81
Paxillin regulates genomic networks in prostate cancer [PC3] 7.78
The DPYSL2 gene connects mTOR and schizophrenia 7.78
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 7.74
SRSF1 role in cellular gene expression and splicing 7.66
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 7.64
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 7.61
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.55
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.53
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 7.5
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 7.49
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.47
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 7.45
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 7.45
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 7.44
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.39
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.39
Statins modulate endothelial transcriptional profile by inhibiting EZH2 7.36
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 7.32
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 7.32
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 7.32
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 7.29
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 7.28
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 7.2
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 7.19
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 7.19
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 6.99
RNA-seq of RKO cells with cTAZ KO or putback 6.96
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.93
Human HAP1 cells before and after nutrient deprivation 6.93
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.93
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 6.9
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.86
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.86
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 6.85
The cohesin complex prevents Myc-induced replication stress 6.83
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.81
ARID1A and ARID1B loss in HCT116 cells 6.81
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 6.77
Total RNA-seq in ALL-SIL upon TLX1 knockdown 6.77
Identification of HOXB13 target genes responsive to BET inhibitors 6.75
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 6.74
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.69
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.69
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 6.58
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 6.52
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 6.42
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 6.4
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.35
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 6.33
RNA seq with AML (NB4) cells upon FTO inhibition 6.33
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 6.32
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 6.3
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 6.29
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 6.22
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 6.18
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 6.16
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.14
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 6.13
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 6.06
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 6.03
Transcriptional profiling of microglia; current state of the art and future perspectives 6.03
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 6.0
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 5.99
RNA editing in nascent RNA affects pre-mRNA splicing 5.95
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 5.86
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 5.86
Systematic discovery of endogenous human ribonucleoprotein complexes 5.83
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.82
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.8
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 5.75
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.72
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 5.71
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 5.71
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.7
RNA splicing alteration on glioblastoma and normal neural stem cells 5.54
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 5.53
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 5.51
Aneuploidy-induced cellular stresses limit autophagic degradation. 5.41
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 5.39
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 5.32
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 5.27
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 5.27
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 5.25
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 5.24
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 5.24
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 5.24
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.21
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.21
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.17
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.17
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.15
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.11
Transcriptome of activated human and mouse MAIT cells 5.04
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.0
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.9
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 4.9
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.9
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.89
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.85
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.85
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 4.84
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 4.82
Global response to chemotherapy-induced apoptosis 4.79
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 4.73
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 4.68
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 4.63
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.63
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.63
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.6
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 4.55
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 4.54
METTL3 and WTAP 4.51
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.47
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.47
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.47
Genome-wide analysis of the Integrator complex 4.37
Genome-wide analysis of the Integrator complex (HTS) 4.37
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 4.36
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.34
IRF1 regulates IFN dependent and independent gene expression 4.28
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 4.23
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.2
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 4.13
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.1
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 4.06
Differentiation enhances Zika virus infection in neuronal brain cells 4.05
LIN28A Over-expression RNAseq 3.99
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.92
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.78
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.78
mRNA expression in human DAOY cells 3.77
Determining mRNA half-lives on a transcriptome-wide scale 3.7
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.68
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.66
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.66
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.65
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 3.6
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.56
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 3.55
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 3.55
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 3.55
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.54
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 3.52
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 3.44
Human Tfh cell RNA bulk sequencing 3.39
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 3.38
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.34
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.29
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 3.24
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.22
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.22
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.2
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.16
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.14
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.13
Gene expression profile in breast cancer cells 3.13
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.12
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 3.11
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 3.11
hnRNP C is a key regulator of protein synthesis in mitosis 3.07
FOXP2's impact on the primate transcriptome 3.03
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.02
Investigate A2M treatment on human prostate cancer xenograft in mice 2.99
Investigate A2M treatment on human prostate cancer and mouse liver 2.99
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.95
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.94
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.86
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 2.83
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 2.83
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.8
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.73
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.71
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.69
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.6
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.55
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.55
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.52
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.46
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.44
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.38
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.36
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.32
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.3
The interplay between SOX4 and SMAD3 in the context of breast cancer 2.27
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 2.24
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.23
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.23
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.2
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.18
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.15
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.99
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.93
Solid phase chemistry to covalently and reversibly capture thiolated RNA 1.93
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.88
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.83
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.8
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.8
Deep RNA sequencing of the human placental transcriptome 1.79
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.77
Specific molecular signatures underlie response to decitabine in CMML 1.77
6mer seed toxicity in viral microRNAs 1.74
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.7
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.69
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 1.65
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.63
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.61
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.61
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.58
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.52
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.48
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.46
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.46
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 1.45
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 1.3
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.28
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.27
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.27
Primary Human B-cell Temporal Response to CD40L Stimulation 1.16
Gene expressions of H9s in different culture systems 1.15
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.09
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.08
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.07
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.04
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 1.03
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 1.03
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.91
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.9
Gene expression profile of CRC-derived HILEC 0.89
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.83
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.83
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.83
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.75
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.74
A single-cell transcriptome atlas of the human pancreas 0.7
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.49
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.49
Targeting MTHFD2 in Acute Myeloid Leukemia 0.45
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.42
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.41
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.41
siRNA-mediated knockdown 0.4
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.35
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.27
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.26
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.26
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.23
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.22
ZIKV infection of monocytes activates inflammasome pathways 0.2
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.2
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.16
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.12
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.12
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.09
Global transcriptome analysis of WT versus HEB-/- hESCs 0.07
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.04
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.04
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation